Wayne,
Here's the link to the BIO 2000 conference in Boston
bio.org
then click on "Sessions & Symposia Descriptions"
then scroll down to review the companies presenting at each Sessions or Symposia.
Jeremy Cook and Ian McBeath will be involved in the following session.
Going Public in Canada: An Alternative or a Prelude to a U.S. IPO?
Chair: Jeremy Curnock Cook, Director, Bioscience Unit, Rothschild Asset Management/Merlin Ventures
Speakers:
Ian McBeath, President and Chief Executive Officer, Inflazyme Pharmaceuticals Ltd.
Ken Galbraith, Senior Vice President and Chief Financial Officer, QLT PhotoTherapeutics Inc.
W.J. (Bill) Adams, C.A., Chief Financial Officer, AnorMED Inc.
William Hunter, Ph.D., M.Sc., Chairman and Chief Executive Officer, Angiotech Pharmaceuticals Inc.
I hope this helps. |
